Syndax Pharmaceuticals Q3 EPS $(0.55) Misses $(0.49) Estimate, Sales $83.298M Beat $81.850M Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.49) by 12.24 percent. This is a 21.43 percent increase over losses of $(0.70) per share from the same period last year. The company reported quarterly sales of $83.298 million which beat the analyst consensus estimate of $81.850 million by 1.77 percent. This is a 81.59 percent increase over sales of $45.871 million the same period last year.